Indian Army Procurement Leh Insulin Lispro & Related Medicines Tender 2026 – ISI/ISO Standards & OEM Authorization

Tender Overview

The Indian Army (Department Of Military Affairs) in Leh, Jammu & Kashmir invites bids for a multi-category pharmaceutical and nutraceutical procurement, including Insulin lispro biphasic inj plain IP, Human Insulin Analogue Glargin inj 100 IU per ml 300IU disposable pen with 5 needles, Calcium plus Vitamin D3 tablets, Clinidipine 5 mg tablets, Omega-3 fatty acids with natural Vitamin E soft gel caps, Atorvastatin 10 mg tablets, Vitamin D3 2000 IU capsules, and a 60 ml bottle of Minoxidil with Finasteride topical solution. The tender references a 9-item BOQ with unspecified quantities and an estimated value, targeting medical and nutrition product categories. A key differentiator is the OEM/MANUFACTURER AUTHORIZATION requirement and a sample approval process prior to bulk manufacturing. The context emphasizes compliance with procurement for defense health supplies under local delivery constraints in LEH. This tender necessitates precise OEM certifications and adherence to advance-sample protocols to qualify for bulk supply.

Technical Specifications & Requirements

• Product/service categories span insulin analogues, cardiovascular medications, vitamins, and dermatological solutions.
• No explicit technical specs published; bidders must align to advance sample approval timelines and contract frameworks.
• Mandatory Manufacturer Authorization from OEMs with full contact details.
• Advance sample submission due within 5 days of contract award; approval or modification list provided within 5 days.
• If buyer delays approval, delivery period is adjusted without LD; major deviations can trigger fresh samples or contract termination.
• All samples for testing are to be provided by the contractor at no cost unless specified otherwise.
• Option clause permits quantity adjustments up to 25% during contract and currency.
• Delivery period mechanics tie to last date of original/extended orders with minimum delivery extension of 30 days.
• No standard numbers for dosage, packaging, or storage found in the available data; bidders should seek detailed technical specs during bid.

Terms, Conditions & Eligibility

• Option Clause allows ordering up to 25% additional quantity at contracted rates during and after the initial delivery period.
• Manufacturer Authorization mandatory; OEM/Original Service Provider details required in the bid (name, designation, address, email, phone).
• Post-award, advance samples must be submitted within 5 days; buyer responds with approval or modification list within 5 days.
• If the buyer delays approval, the delivery period may be refixed without LD for the delay.
• If samples are non-conforming, buyer may require new samples or terminate the contract after notifying deviations.
• Common tender artifacts like GST, PAN, experience certificates, financial statements, EMD documentation, technical compliance and OEM authorizations are typically required; explicit items not disclosed here.